Paul A. Wagner Forte Biosciences, Inc. (FBRX) insider trading activity

Paul A. Wagner is of Forte Biosciences, Inc.. Currently has a direct ownership of 77,470 shares of FBRX, which is worth approximately $1.55 Million. The most recent transaction as insider was on Oct 01, 2024, when has been sold 98 shares (Common Stock) at a price of $5.16 per share, resulting in proceeds of $505. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77.5K

95.94% 3M change

95.75% 12M change

Total Value Held $1.55 Million

Paul A. Wagner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 01 2024	SELL Payment of exercise price or tax liability	$505 $5.16 p/Share	98 Reduced 0.13%	77,470 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	-	1,250 Added 1.59%	77,568 Common Stock
Jul 01 2024	SELL Payment of exercise price or tax liability	$1,349 $0.55 p/Share	2,453 Reduced 0.13%	1,907,971 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	-	31,250 Added 1.61%	1,910,424 Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$1,741 $0.71 p/Share	2,453 Reduced 0.13%	1,879,174 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	-	31,250 Added 1.63%	1,881,627 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$3,369 $0.82 p/Share	4,109 Reduced 0.22%	1,850,377 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	31,250 Added 1.66%	1,854,486 Common Stock
Dec 18 2023	BUY Open market or private purchase	$7,500 $0.75 p/Share	10,000 Added 0.55%	1,823,236 Common Stock
Dec 14 2023	BUY Open market or private purchase	$7,200 $0.72 p/Share	10,000 Added 0.55%	1,813,236 Common Stock
Dec 13 2023	BUY Open market or private purchase	$7,363 $0.7 p/Share	10,520 Added 0.58%	1,803,236 Common Stock
Dec 12 2023	BUY Open market or private purchase	$3,104 $0.65 p/Share	4,776 Added 0.27%	1,792,716 Common Stock
Dec 11 2023	BUY Open market or private purchase	$16,250 $0.65 p/Share	25,000 Added 1.38%	1,787,940 Common Stock
Dec 08 2023	BUY Open market or private purchase	$9,300 $0.62 p/Share	15,000 Added 0.84%	1,762,940 Common Stock
Dec 07 2023	BUY Open market or private purchase	$20,997 $0.58 p/Share	36,203 Added 2.03%	1,747,940 Common Stock
Nov 22 2023	BUY Open market or private purchase	$172 $0.43 p/Share	400 Added 0.02%	1,711,737 Common Stock
Nov 20 2023	BUY Open market or private purchase	$2,995 $0.43 p/Share	6,966 Added 0.41%	1,711,337 Common Stock
Oct 01 2023	SELL Payment of exercise price or tax liability	$1,618 $0.66 p/Share	2,453 Reduced 0.14%	1,704,371 Common Stock
Oct 01 2023	BUY Exercise of conversion of derivative security	-	31,250 Added 1.8%	1,706,824 Common Stock
Jul 31 2023	BUY Grant, award, or other acquisition	$249,999 $1.01 p/Share	247,524 Added 12.87%	1,675,574 Common Stock
Jul 01 2023	SELL Payment of exercise price or tax liability	$2,551 $1.04 p/Share	2,453 Reduced 0.17%	1,428,050 Common Stock
Jul 01 2023	BUY Exercise of conversion of derivative security	-	31,250 Added 2.14%	1,430,503 Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$11,156 $1.01 p/Share	11,046 Reduced 0.78%	1,399,253 Common Stock
Apr 01 2023	BUY Exercise of conversion of derivative security	-	31,250 Added 2.17%	1,410,299 Common Stock
Dec 16 2022	BUY Open market or private purchase	$47,105 $1.07 p/Share	44,024 Added 3.09%	1,379,049 Common Stock

PAW

Paul A. Wagner

Torrance, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FBRX shares.

Notify only if

Value

Insider Trading

Get notified when an Forte Biosciences, Inc. insider buys or sells FBRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Forte Biosciences, Inc.

Track Activities on FBRX

Account